Literature DB >> 10779347

Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

M J Aman1, S F Walk, M E March, H P Su, D J Carver, K S Ravichandran.   

Abstract

The inositol phosphatase SHIP binds to the FcgammaRIIB1 receptor and plays a critical role in FcgammaRIIB1-mediated inhibition of B-cell proliferation and immunoglobulin synthesis. The molecular details of SHIP function are not fully understood. While point mutations of the signature motifs in the inositol phosphatase domain abolish SHIP's ability to inhibit calcium flux in B cells, little is known about the function of the evolutionarily conserved, putative noncatalytic regions of SHIP in vivo. In this study, through a systematic mutagenesis approach, we identified the inositol phosphatase domain of SHIP between amino acids 400 and 866. Through reconstitution of a SHIP-deficient B-cell line with wild-type and mutant forms of SHIP, we demonstrate that the catalytic domain alone is not sufficient to mediate FcgammaRIIB1/SHIP-dependent inhibition of B-cell receptor signaling. Expression of a truncation mutant of SHIP that has intact phosphatase activity but lacks the last 190 amino acids showed that the noncatalytic region in the C terminus is essential for inhibitory signaling. Mutation of two tyrosines within this C-terminal region, previously identified as important in binding to Shc, showed a reduced inhibition of calcium flux. However, studies with an Shc-deficient B-cell line indicated that Shc-SHIP complex formation is not required and that other proteins that bind these tyrosines may be important in FcgammaRIIB1/SHIP-mediated calcium inhibition. Interestingly, membrane targeting of SHIP lacking the C terminus is able to restore this inhibition, suggesting a role for the C terminus in localization or stabilization of SHIP interaction at the membrane. Taken together, these data suggest that the noncatalytic carboxyl-terminal 190 amino acids of SHIP play a critical role in SHIP function in B cells and may play a similar role in several other receptor systems where SHIP functions as a negative regulator.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779347      PMCID: PMC85650          DOI: 10.1128/MCB.20.10.3576-3589.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.

Authors:  M R Gold; M P Scheid; L Santos; M Dang-Lawson; R A Roth; L Matsuuchi; V Duronio; D L Krebs
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

2.  Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli.

Authors:  M W Pantoliano; R E Bird; S Johnson; E D Asel; S W Dodd; J F Wood; K D Hardman
Journal:  Biochemistry       Date:  1991-10-22       Impact factor: 3.162

3.  Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc.

Authors:  L Liu; J E Damen; R L Cutler; G Krystal
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

4.  Cross-linking of Fc gamma receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel.

Authors:  M L Diegel; B M Rankin; J B Bolen; P M Dubois; P A Kiener
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

5.  B cell antigen receptor stimulation induces formation of a Shc-Grb2 complex containing multiple tyrosine-phosphorylated proteins.

Authors:  L Smit; A M de Vries-Smits; J L Bos; J Borst
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

6.  B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein.

Authors:  T M Saxton; I van Oostveen; D Bowtell; R Aebersold; M R Gold
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

7.  Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein.

Authors:  J E Damen; L Liu; R L Cutler; G Krystal
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

8.  Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation.

Authors:  K S Ravichandran; K K Lee; Z Songyang; L C Cantley; P Burn; S J Burakoff
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

9.  Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.

Authors:  M R Gold; R Aebersold
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

10.  Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways.

Authors:  M Takata; H Sabe; A Hata; T Inazu; Y Homma; T Nukada; H Yamamura; T Kurosaki
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  12 in total

1.  The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1.

Authors:  Jing Ai; Amita Maturu; Wesley Johnson; Yijie Wang; Clay B Marsh; Susheela Tridandapani
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

2.  A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).

Authors:  Jun Zhang; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

3.  5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.

Authors:  V Taylor; M Wong; C Brandts; L Reilly; N M Dean; L M Cowsert; S Moodie; D Stokoe
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 4.  Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes.

Authors:  Wai-Hang Leung; Tatyana Tarasenko; Silvia Bolland
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

5.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

6.  NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis.

Authors:  Chang Yang; Kathleen McCoy; Jennifer L Davis; Marc Schmidt-Supprian; Yoshiteru Sasaki; Roberta Faccio; Deborah Veis Novack
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

7.  Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.

Authors:  Shari Pilon-Thomas; Nadine Nelson; Nasreen Vohra; Maya Jerald; Laura Pendleton; Karoly Szekeres; Tomar Ghansah
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

8.  The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.

Authors:  Claude Condé; Xavier Rambout; Marielle Lebrun; Aurore Lecat; Emmanuel Di Valentin; Franck Dequiedt; Jacques Piette; Geoffrey Gloire; Sylvie Legrand
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

9.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

Review 10.  Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.

Authors:  Shannon M Kelley; Kodi S Ravichandran
Journal:  EMBO Rep       Date:  2021-05-27       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.